This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Flamel Technologies CEO Discusses Q3 2010 Results - Earnings Call Transcript

Flamel Technologies SA ( FLML)

Q3 2010 Earnings Call Transcript

November 5, 2010 8:30 am ET

Executives

Stephen Willard – CEO

Sian Crouzet – Principal Financial Officer

Analysts

Matt Kaplan – Ladenburg Thalmann

David Moskowitz – Madison Williams

Presentation

Operator

Good morning, ladies and gentlemen, and welcome to the Flamel Technologies third quarter 2010 earnings conference call. Please note that this call is being recorded. There will be a question and answer session, following today's presentation. (Operator Instructions)

I would now like to turn the call over to Mr. Stephen Willard, CEO. Please go ahead, sir.

Stephen Willard

Yes. Thank you. Good morning, everyone and thank you for joining our call today. As always, we open with the forward-looking statement language, which is set out at the conclusion of yesterday's press release. All statements made on this call are subject to a variety of future events and risk factors, including those set forth in our filings with the SEC, particularly our Form 20-F, which are all publicly available. Please review them, as they are directly applicable to every element of this call.

Since our last quarterly call in August, we have been progressing well on our major projects. Last month, we announced the achievement of the 3 million euro clinical development milestone and our development of an extended release formula for Merck Serono. The molecule we've been working on with Merck Serono is beta interferon 1a. Yesterday, we announced the achievement of a second additional milestone for the same program. According to the terms that we initially negotiated in 2007, we will receive a further $1 million milestone payment.

1 of 3

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
SYM TRADE IT LAST %CHG

Markets

DOW 18,232.02 -53.72 -0.29%
S&P 500 2,126.06 -4.76 -0.22%
NASDAQ 5,089.3620 -1.4320 -0.03%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs